Skip to main content

Table 1 Cohort creation and distribution of follow-up time

From: Comparative effectiveness of home dialysis therapies: a matched cohort study

Criterion or variable

Daily home HD

Home PD

Patients age ≥18 years, n

4509

208,086

Exclusions, n (%)

 Not in the time windowa

1067 (23.7)

119,974 (57.7)

 Nonindependent living

166 (3.7)

4355 (2.1)

 Missing race

0 (0)

47 (0)

 Missing comorbidity

0 (0)

8 (0)

 Missing weight

55 (1.2)

6910 (3.3)

 Albumin <1.0 or Hgb <5

25 (0.6)

754 (0.4)

 Prior transplants >2

3 (0.1)

49 (0)

 Follow-up <30 days

51 (1.1)

1067 (0.5)

 Total excluded

1367 (30.3)

133,164 (64.0)

Eligible, n (%)

3142 (69.7)

74,922 (36.0)

Matched,b n (%)

2668 (80.0)

2668 (3.6)

Follow-up time (years)

 Mean (SD)

1.9 (1.3)

2.0 (1.4)

 Median (IQR)

1.7 (0.8–2.8)

1.7 (0.9–2.9)

 Range

0.1–6.5

0.1–7.2

  1. aThe time window was defined as having started renal replacement therapy after 1995 and having started PD or daily HD between 2004 and 2011. Patients missing one or more of the following comorbidities were excluded: cancer, hypertension, congestive heart failure, cerebrovascular disease, peripheral vascular disease, chronic obstructive pulmonary disease, and diabetes
  2. bThe percentage matched was calculated as the proportion of eligible patients that were matched